Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer

By sjmartinez • March 11, 2025

Zhang L, Teng PC, Cavassani KA, Wang J, Grasso C, Watson J, Chen Z, Tu KH, Salumbides B, Rohena-Rivera K, Gevorkian L, Kim M, You S, Di Vizio D, Sandler HM, Daskivich T, Bhowmick NA, Freeman MR, Tseng HR, Chen JF, Posadas EM. Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer. Clin Cancer Res. 2025 Mar 10. doi: 10.1158/1078-0432.CCR-24-3660. Epub ahead of print. PMID: 40063516.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method

Devi J, Samaan S, Sehgal P, Mohamed M, Vincent M, Coombs S, Doering M, Barnes EL, Johnson AM, Yarur AJ, Deepak P. Modulate Obesity and[...]

Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of[...]

Prenatal Substance Exposure and Birth Weight: Findings From the HEALthy Brain and Child Development Study

Bandoli G, Psaras C, Bakhireva LN, Burris HH, Ciciolla L, Coles CD, DeMauro SB, Osmundson SS, Merhar SL, Smith L, Acheson A, Bogdan R, Croff[...]